{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T20:00:31Z","timestamp":1720382431252},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"from Gan-Po 555 project of Jiangxi"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.leukres.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T22:31:50Z","timestamp":1503700310000},"page":"39-43","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification"],"prefix":"10.1016","volume":"61","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Pourabdollah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eshetu G.","family":"Atenafu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tierens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Schimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.leukres.2017.08.011_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"issue":"September (9)","key":"10.1016\/j.leukres.2017.08.011_bib0010","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5858\/2009-0350-RA.1","article-title":"Acute erythroid leukemia","volume":"134","author":"Zuo","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.leukres.2017.08.011_bib0015","series-title":"WHO Classification of Tumours","first-page":"1","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.leukres.2017.08.011_bib0020","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","article-title":"Acute myeloid leukaemia, not otherwise specified","author":"Arber","year":"2008"},{"issue":"1","key":"10.1016\/j.leukres.2017.08.011_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1309\/AJCPRKYAT6EZQHC7","article-title":"Acute erythroleukemias, acute megakaryoblastic leukemias and reactive mimics: a guide to a number of perplexing entities","volume":"144","author":"Wang","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2017.08.011_bib0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/modpathol.2010.96","article-title":"Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease","volume":"23","author":"Kasyan","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.leukres.2017.08.011_bib0035","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"November (11)","key":"10.1016\/j.leukres.2017.08.011_bib0040","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/ajh.23834","article-title":"Acute myeloid leukemia: 2014 update on risk-stratification and management","volume":"89","author":"Estey","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2017.08.011_bib0045","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"October","key":"10.1016\/j.leukres.2017.08.011_bib0050","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/modpathol.2016.118","article-title":"Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts","volume":"29","author":"Wang","year":"2016","journal-title":"Mod. Pathol."},{"issue":"December","key":"10.1016\/j.leukres.2017.08.011_bib0055","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/modpathol.2016.146","article-title":"Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes","volume":"29","author":"Calvo","year":"2016","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2017.08.011_bib0060","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2013.144","article-title":"Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics","volume":"27","author":"Grossmann","year":"2013","journal-title":"Leukemia"},{"issue":"December (2)","key":"10.1016\/j.leukres.2017.08.011_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2005.05.006","article-title":"Cytogenetic study of 75 erythroleukemias","volume":"163","author":"Lessard","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"issue":"7","key":"10.1016\/j.leukres.2017.08.011_bib0070","doi-asserted-by":"crossref","first-page":"e41485","DOI":"10.1371\/journal.pone.0041485","article-title":"Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML","volume":"7","author":"Zuo","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.leukres.2017.08.011_bib0075","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3324\/haematol.2011.050526","article-title":"Acute myeloid leukemia with expanded erythropoiesis","volume":"96","author":"Porwit","year":"2011","journal-title":"Haematologica"},{"issue":"August","key":"10.1016\/j.leukres.2017.08.011_bib0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.leukres.2016.05.006","article-title":"Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: is there biologic significance? (How should blasts be counted?)","volume":"47","author":"Bennett","year":"2016","journal-title":"Leuk. Res."},{"issue":"10","key":"10.1016\/j.leukres.2017.08.011_bib0085","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2009-09-243964","article-title":"Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification","volume":"115","author":"Hasserjian","year":"2010","journal-title":"Blood"},{"issue":"April (4)","key":"10.1016\/j.leukres.2017.08.011_bib0090","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/leu.2015.198","article-title":"Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing","volume":"30","author":"Cervera","year":"2016","journal-title":"Leukemia"},{"issue":"March","key":"10.1016\/j.leukres.2017.08.011_bib0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOH.0000000000000314","article-title":"Revisiting erythroleukemia","volume":"24","author":"Arber","year":"2017","journal-title":"Curr. Opin. Hematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:08:13Z","timestamp":1620979693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617304927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":19,"alternative-id":["S0145212617304927"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.08.011","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}